Inquis Medical, Inc., a privately held medical technology company dedicated to advancing mechanical thrombectomy for venous thromboembolic disease (“VTE”), t…
MENLO PARK, Calif.–(BUSINESS WIRE)–Inquis Medical, Inc., a privately held medical technology company dedicated to advancing mechanical thrombectomy for venous thromboembolic disease (“VTE”), today announced the closing of a $75 million Series C fin… [3036 chars]
Source: Business Wire | Published: 2026-01-12T16:01:00Z
Credit: Business Wire
